Qiyu Jiang

Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents

Hui Jia, Qian Yang, Tao Wang et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2016 · 111 citations

Chemotherapeutic Agents, Oncology, Medicine +9

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

Fan Feng, Qiyu Jiang, Shuang Cao et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2018 · 105 citations

Oncology, Hepatology, Medicine +8

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

Yingshi Zhang, Dandan Li, Qiyu Jiang et al. · Cell Death and Disease · 2018 · 104 citations · Full text

ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR

Zhi‐Yi Shao, Yibo Li, Wenjie Dai et al. · Pharmacological Research · 2018 · 85 citations

Tumor Biology, Transcriptional Regulation, Ets-1 Induces Sorafenib-resistance +13

Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells <i>via</i> the miR-148a/PXR axis

Boan Li, Fan Feng, Hui Jia et al. · Food & Function · 2021 · 79 citations